May 8, 2013
AnGes MG hopes to initiate a global PIII clinical trial in the US and Europe by the end of this year for its investigational hepatocyte growth factor gene treatment Collategene (beperminogene perplasmid) for critical limb ischemia, President Ei Yamada said...read more